Research Progress of COL5A1 in Osteosarcoma
DOI:
https://doi.org/10.54097/rp92er47Keywords:
COL5A1, Collagen V Alpha 1 Chain, Osteosarcoma, Extracellular Matrix, BiomarkerAbstract
COL5A1 (Collagen V alpha 1 chain) has gained significant attention as an important component of the extracellular matrix in recent osteosarcoma research. This review aims to summarize the expression characteristics, functional mechanisms, and potential clinical applications of COL5A1 in the context of osteosarcoma. By examining the latest findings, we delve into the role of COL5A1 in promoting osteosarcoma cell proliferation, migration, and invasion, while also assessing its potential as a biomarker and therapeutic target. Through this comprehensive analysis, we hope to provide valuable insights that can guide future research and clinical applications in this crucial area of oncology.
Downloads
References
[1] Lu X, Duan A, Liang S, Ma X, Deng T: Genomic Identification, Evolution, and Expression Analysis of Collagen Genes Family in Water Buffalo during Lactation. Genes (Basel) 2020, 11.
[2] Bronner-Shtrauchler O, Nativ-Roth E, Sanchez DS, Zaiden M, Vidavsky N: Multimodal characterization of the collagen hydrogel structure and properties in response to physiologically relevant pH fluctuations. Acta Biomater 2024, 178:170-180.
[3] Cui J, Dean D, Hornicek FJ, Yi G, Duan Z: Expression and Clinical Significance of High-Mobility Group AT-hook 2 (HMGA2) in Osteosarcoma. Orthop Surg 2022, 14:955-966.
[4] Hashimoto K, Nishimura S, Akagi M: Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma. Diagnostics (Basel) 2020, 10.
[5] Yang S, Liu L, Liu X, Li X, Zheng Y, Ren Z, Wang R, Wang Y, Li Q: The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma. Medicine (Baltimore) 2023, 102:e36046.
[6] Colman M, Syx D, De Wandele I, Dhooge T, Symoens S, Malfait F: Clinical and molecular characteristics of 168 probands and 65 relatives with a clinical presentation of classical Ehlers-Danlos syndrome. Hum Mutat 2021, 42:1294-1306.
[7] Wu M, Sun Q, Mo CH, Pang JS, Hou JY, Pang LL, Lu HP, Dang YW, Fang SJ, Tang D, et al: Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry. Oncol Rep 2019, 42:151-175.
[8] Duan X, Ye D, Yuan J, Guan B, Guan W, Liu S, Fang J, Shi J, Zhu Y, Li Q, et al: COL5A1 overexpression correlates with poor prognosis in human cervical cancer. Int J Biol Markers 2024, 39:265-273.
[9] Sun M, Acosta AC, Emerick V, Adams S, Avila MY, Margo CE, Espana EM: Dysfunctional latent transforming growth factor β activation after corneal injury in a classical Ehlers-Danlos model. Matrix Biol 2024, 128:21-30.
[10] Machol K, Polak U, Weisz-Hubshman M, Song IW, Chen S, Jiang MM, Chen-Evenson Y, Weis MAE, Keene DR, Eyre DR, Lee BH: Molecular alterations due to Col5a1 haploinsufficiency in a mouse model of classic Ehlers-Danlos syndrome. Hum Mol Genet 2022, 31:1325-1335.
[11] Gu S, Peng Z, Wu Y, Wang Y, Lei D, Jiang X, Zhao H, Fu P: COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas. Front Oncol 2021, 11:752694.
[12] Dong C, Zhao Y, Yang S, Jiao X: LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma. J Oral Pathol Med 2023, 52:493-503.
[13] Lin P, Zhang G, Peng R, Zhao M, Li H: Increased expression of bone/cartilage-associated genes and core transcription factors in keloids by RNA sequencing. Exp Dermatol 2022, 31:1586-1596.
[14] Leiphart RJ, Weiss SN, DiStefano MS, Mavridis AA, Adams SA, Dyment NA, Soslowsky LJ: Collagen V deficiency during murine tendon healing results in distinct healing outcomes based on knockdown severity. J Biomech 2022, 144:111315.
[15] Leone MP, Morlino S, Nardella G, Pracella R, Giachino D, Celli L, Baldo D, Turolla L, Piccione M, Salzano E, et al: Specifications and validation of the ACMG/AMP criteria for clinical interpretation of sequence variants in collagen genes associated with joint hypermobility. Hum Genet 2023, 142:785-808.
[16] Zhu G, Wang Y, Wang Y, Huang H, Li B, Chen P, Chen C, Zhang H, Li Y, Liu H, Chen J: Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells. Cell Death Dis 2024, 15:493.
[17] Jin L, Ma J, Chen Z, Wang F, Li Z, Shang Z, Dong J: Osteoarthritis related epigenetic variations in miRNA expression and DNA methylation. BMC Med Genomics 2023, 16:163.
[18] Feng G, Ma HM, Huang HB, Li YW, Zhang P, Huang JJ, Cheng L, Li GR: Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma. Cancer Manag Res 2019, 11:1263-1274.
[19] Zhu H, Hu X, Feng S, Jian Z, Xu X, Gu L, Xiong X: The Hypoxia-Related Gene COL5A1 Is a Prognostic and Immunological Biomarker for Multiple Human Tumors. Oxid Med Cell Longev 2022, 2022:6419695.
[20] Zhang J, Zhang J, Wang F, Xu X, Li X, Guan W, Men T, Xu G: Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer. J Cell Physiol 2021, 236:6907-6919.
[21] Wang C, Wang Y, Fu Z, Huang W, Yu Z, Wang J, Zheng K, Zhang S, Li S, Chen J: MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1. Front Oncol 2022, 12:837581.
[22] Gong H, Wu W, Fang C, He D: CircBFAR correlates with poor prognosis and promotes laryngeal squamous cell cancer progression through miR-31-5p/COL5A1 axis. Laryngoscope Investig Otolaryngol 2022, 7:1951-1962.
[23] Chen P, Yu B, Li Z, Chen Y, Sun Y, Wang DW: COL5A1 Variants Cause Aortic Dissection by Activating TGF-β-Signaling Pathway. J Am Heart Assoc 2021, 10:e019276.
[24] Chen X, Ma C, Li Y, Liang Y, Chen T, Han D, Luo D, Zhang N, Zhao W, Wang L, Yang Q: COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk. Oncogene 2024, 43:1742-1756.
[25] Hu C, Zuo Q, Jin K, Zhao Z, Wu Y, Gao J, Wang C, Wang Y, Zhan W, Zhou J, et al: Retinoic acid promotes formation of chicken (Gallus gallus) spermatogonial stem cells by regulating the ECM-receptor interaction signaling pathway. Gene 2022, 820:146227.
[26] Wei Z, Chen L, Meng L, Han W, Huang L, Xu A: LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1. Gastric Cancer 2020, 23:1018-1032.
[27] Xue J, Zhu S, Qi F, Zhu K, Cao P, Yang J, Wang Z: RUNX1/miR-582-5p Pathway Regulates the Tumor Progression in Clear Cell Renal Cell Carcinoma by Targeting COL5A1. Front Oncol 2021, 11:610992.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

